Procrit
NDC Package 54868-5673-1
Package Information
Procrit is a medication used to treat anemia (low red blood cell count) in people with long-term serious kidney disease (chronic kidney failure), people receiving zidovudine to treat HIV, and people receiving chemotherapy for some types of cancer (cancer that does not involve the bone marrow or blood cells). Marketed by Physicians Total Care, Inc., this product is identified by NDC 54868-5673 and is authorized under FDA application BLA103234.
Identification & Billing
- RxCUI: 1721684 - epoetin alfa 10,000 UNT in 1 ML Injection
- RxCUI: 1721684 - 1 ML epoetin alfa 10000 UNT/ML Injection
- RxCUI: 1721684 - 1 ML EPO 10000 UNT/ML Injection
- RxCUI: 1721684 - 1 ML ERYTHROPOIETIN 10000 UNT/ML Injection
- RxCUI: 1721684 - epoetin alfa 10,000 UNT per 1 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54868 - Physicians Total Care, Inc.
- 54868-5673 - Procrit
- 54868-5673-1 - 4 VIAL, MULTI-DOSE in 1 CARTON / 1 mL in 1 VIAL, MULTI-DOSE
- 54868-5673 - Procrit
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54868-5673-1 identifies a specific commercial package of 4 vial, multi-dose in 1 carton / 1 ml in 1 vial, multi-dose of Procrit, labeled by Physicians Total Care, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Physicians Total Care, Inc. on March 24, 2008. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
This medication is used to treat anemia (low red blood cell count) in people with long-term serious kidney disease (chronic kidney failure), people receiving zidovudine to treat HIV, and people receiving chemotherapy for some types of cancer (cancer that does not involve the bone marrow or blood cells). It may also be used in anemic patients to reduce the need for blood transfusions before certain planned surgeries that have a high risk of blood loss (usually given with an anticoagulant/"blood thinner" medication such as warfarin to lower the risk of serious blood clots). Epoetin alfa works by signaling the bone marrow to make more red blood cells. This medication is very similar to the natural substance in your body (erythropoietin) that prevents anemia.
How is this Physicians Total Care, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54868567301. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
